Loading…
Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements
BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe u...
Saved in:
Published in: | Open heart 2024-12, Vol.11 (2), p.e002884 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843 |
container_end_page | |
container_issue | 2 |
container_start_page | e002884 |
container_title | Open heart |
container_volume | 11 |
creator | Chang, Rachel Si-Wen Chiu, I-min Tacon, Phillip Abiragi, Michael Cao, Louie Hong, Gloria Le, Jonathan Zou, James Daluwatte, Chathuri Ricchiuto, Piero Ouyang, David |
description | BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe used 3603 echocardiogram studies from 636 patients at Cedars-Sinai Medical Center to train an RF model to predict CA from echocardiographic parameters. 231 patients with CA were compared with 405 control patients with negative pyrophosphate scans or clinical diagnosis of hypertrophic cardiomyopathy. 19 common echocardiographic measurements from echocardiogram reports were used as input into the RF model. Data was split by patient into a training data set of 2882 studies from 486 patients and a test data set of 721 studies from 150 patients. The performance of the model was evaluated by area under the receiver operative curve (AUC), sensitivity, specificity and positive predictive value (PPV) on the test data set.ResultsThe RF model identified CA with an AUC of 0.84, sensitivity of 0.82, specificity of 0.73 and PPV of 0.76. Some echocardiographic measurements had high missingness, suggesting gaps in measurement in routine clinical practice. Features that were large contributors to the model included mitral A-wave velocity, global longitudinal strain (GLS), left ventricle posterior wall diameter end diastolic (LVPWd) and left atrial area.ConclusionMachine learning on echocardiographic parameters can detect patients with CA with accuracy. Our model identified several features that were major contributors towards identifying CA including GLS, mitral A peak velocity and LVPWd. Further study is needed to evaluate its external validity and application in clinical settings. |
doi_str_mv | 10.1136/openhrt-2024-002884 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_cc8304af7f82460db39ee3d2d07077c8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_cc8304af7f82460db39ee3d2d07077c8</doaj_id><sourcerecordid>3147673082</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843</originalsourceid><addsrcrecordid>eNpdkktv1DAUhS0EotXQX4CEIrFhE3r9iB2vECqvSpXYwNpy7JsZj5J4sBOk_vs6MwO0rGzde-7nY_sQ8prCe0q5vI4HnHZprhkwUQOwthXPyCWDhtdcMvH80f6CXOW8BwDKGglaviQXXEstGiUuif2EM7o5xKmKfeVs8sG6yo73Qww-5pCrJYdpW43W7cKE1YA2TWuhDKS4zGsN3S4eJ-M22cMuuGpEm5eEI05zfkVe9HbIeHVeN-Tnl88_br7Vd9-_3t58vKs7JqSom05S1Nox3XurAZUGKqGXjWRSMcVRd53DzjqHXradA-Be9Aot5xp9K_iG3J64Ptq9OaQw2nRvog3mWIhpa2yagxvQONdyELZXfVvOBt8VBHLPPChQqjQ35MOJdVi6Eb0r90h2eAJ92pnCzmzjb0OplErw1c27MyHFXwvm2YwhOxwGO2FcsuFUKFpMKF6kb_-T7uOSpvJWR5VUHFpWVG8eW_rr5c9XFsH1SdCN-38ECmbNiznnxax5Mae88AeRGbQx</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3147673082</pqid></control><display><type>article</type><title>Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements</title><source>BMJ Open Access Journals</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Chang, Rachel Si-Wen ; Chiu, I-min ; Tacon, Phillip ; Abiragi, Michael ; Cao, Louie ; Hong, Gloria ; Le, Jonathan ; Zou, James ; Daluwatte, Chathuri ; Ricchiuto, Piero ; Ouyang, David</creator><creatorcontrib>Chang, Rachel Si-Wen ; Chiu, I-min ; Tacon, Phillip ; Abiragi, Michael ; Cao, Louie ; Hong, Gloria ; Le, Jonathan ; Zou, James ; Daluwatte, Chathuri ; Ricchiuto, Piero ; Ouyang, David</creatorcontrib><description>BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe used 3603 echocardiogram studies from 636 patients at Cedars-Sinai Medical Center to train an RF model to predict CA from echocardiographic parameters. 231 patients with CA were compared with 405 control patients with negative pyrophosphate scans or clinical diagnosis of hypertrophic cardiomyopathy. 19 common echocardiographic measurements from echocardiogram reports were used as input into the RF model. Data was split by patient into a training data set of 2882 studies from 486 patients and a test data set of 721 studies from 150 patients. The performance of the model was evaluated by area under the receiver operative curve (AUC), sensitivity, specificity and positive predictive value (PPV) on the test data set.ResultsThe RF model identified CA with an AUC of 0.84, sensitivity of 0.82, specificity of 0.73 and PPV of 0.76. Some echocardiographic measurements had high missingness, suggesting gaps in measurement in routine clinical practice. Features that were large contributors to the model included mitral A-wave velocity, global longitudinal strain (GLS), left ventricle posterior wall diameter end diastolic (LVPWd) and left atrial area.ConclusionMachine learning on echocardiographic parameters can detect patients with CA with accuracy. Our model identified several features that were major contributors towards identifying CA including GLS, mitral A peak velocity and LVPWd. Further study is needed to evaluate its external validity and application in clinical settings.</description><identifier>ISSN: 2053-3624</identifier><identifier>ISSN: 2398-595X</identifier><identifier>EISSN: 2053-3624</identifier><identifier>DOI: 10.1136/openhrt-2024-002884</identifier><identifier>PMID: 39694574</identifier><language>eng</language><publisher>England: British Cardiovascular Society</publisher><subject>Accuracy ; Aged ; Amyloidosis ; Amyloidosis - diagnosis ; Amyloidosis - diagnostic imaging ; Amyloidosis - physiopathology ; Artificial intelligence ; Cardiac arrhythmia ; Cardiomyopathies - diagnosis ; Cardiomyopathies - diagnostic imaging ; Cardiomyopathies - physiopathology ; Cardiomyopathy, Restrictive ; Cardiovascular disease ; Coronary vessels ; Deep learning ; Diabetes ; Diagnostic Imaging ; Echocardiography ; Echocardiography - methods ; Ejection fraction ; Feature selection ; Female ; Heart failure ; Heart Failure and Cardiomyopathies ; Humans ; Hypertension ; Machine Learning ; Male ; Middle Aged ; Original Research ; Patients ; Performance evaluation ; Predictive Value of Tests ; Pulmonary arteries ; Reproducibility of Results ; Retrospective Studies ; Statistical analysis ; Ultrasonic imaging ; Vein & artery diseases</subject><ispartof>Open heart, 2024-12, Vol.11 (2), p.e002884</ispartof><rights>Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843</cites><orcidid>0000-0002-8969-2757</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3147673082/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3147673082?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,55350,75126,77660,77686</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39694574$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, Rachel Si-Wen</creatorcontrib><creatorcontrib>Chiu, I-min</creatorcontrib><creatorcontrib>Tacon, Phillip</creatorcontrib><creatorcontrib>Abiragi, Michael</creatorcontrib><creatorcontrib>Cao, Louie</creatorcontrib><creatorcontrib>Hong, Gloria</creatorcontrib><creatorcontrib>Le, Jonathan</creatorcontrib><creatorcontrib>Zou, James</creatorcontrib><creatorcontrib>Daluwatte, Chathuri</creatorcontrib><creatorcontrib>Ricchiuto, Piero</creatorcontrib><creatorcontrib>Ouyang, David</creatorcontrib><title>Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements</title><title>Open heart</title><addtitle>Open Heart</addtitle><addtitle>Open Heart</addtitle><description>BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe used 3603 echocardiogram studies from 636 patients at Cedars-Sinai Medical Center to train an RF model to predict CA from echocardiographic parameters. 231 patients with CA were compared with 405 control patients with negative pyrophosphate scans or clinical diagnosis of hypertrophic cardiomyopathy. 19 common echocardiographic measurements from echocardiogram reports were used as input into the RF model. Data was split by patient into a training data set of 2882 studies from 486 patients and a test data set of 721 studies from 150 patients. The performance of the model was evaluated by area under the receiver operative curve (AUC), sensitivity, specificity and positive predictive value (PPV) on the test data set.ResultsThe RF model identified CA with an AUC of 0.84, sensitivity of 0.82, specificity of 0.73 and PPV of 0.76. Some echocardiographic measurements had high missingness, suggesting gaps in measurement in routine clinical practice. Features that were large contributors to the model included mitral A-wave velocity, global longitudinal strain (GLS), left ventricle posterior wall diameter end diastolic (LVPWd) and left atrial area.ConclusionMachine learning on echocardiographic parameters can detect patients with CA with accuracy. Our model identified several features that were major contributors towards identifying CA including GLS, mitral A peak velocity and LVPWd. Further study is needed to evaluate its external validity and application in clinical settings.</description><subject>Accuracy</subject><subject>Aged</subject><subject>Amyloidosis</subject><subject>Amyloidosis - diagnosis</subject><subject>Amyloidosis - diagnostic imaging</subject><subject>Amyloidosis - physiopathology</subject><subject>Artificial intelligence</subject><subject>Cardiac arrhythmia</subject><subject>Cardiomyopathies - diagnosis</subject><subject>Cardiomyopathies - diagnostic imaging</subject><subject>Cardiomyopathies - physiopathology</subject><subject>Cardiomyopathy, Restrictive</subject><subject>Cardiovascular disease</subject><subject>Coronary vessels</subject><subject>Deep learning</subject><subject>Diabetes</subject><subject>Diagnostic Imaging</subject><subject>Echocardiography</subject><subject>Echocardiography - methods</subject><subject>Ejection fraction</subject><subject>Feature selection</subject><subject>Female</subject><subject>Heart failure</subject><subject>Heart Failure and Cardiomyopathies</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Machine Learning</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original Research</subject><subject>Patients</subject><subject>Performance evaluation</subject><subject>Predictive Value of Tests</subject><subject>Pulmonary arteries</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Statistical analysis</subject><subject>Ultrasonic imaging</subject><subject>Vein & artery diseases</subject><issn>2053-3624</issn><issn>2398-595X</issn><issn>2053-3624</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>9YT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkktv1DAUhS0EotXQX4CEIrFhE3r9iB2vECqvSpXYwNpy7JsZj5J4sBOk_vs6MwO0rGzde-7nY_sQ8prCe0q5vI4HnHZprhkwUQOwthXPyCWDhtdcMvH80f6CXOW8BwDKGglaviQXXEstGiUuif2EM7o5xKmKfeVs8sG6yo73Qww-5pCrJYdpW43W7cKE1YA2TWuhDKS4zGsN3S4eJ-M22cMuuGpEm5eEI05zfkVe9HbIeHVeN-Tnl88_br7Vd9-_3t58vKs7JqSom05S1Nox3XurAZUGKqGXjWRSMcVRd53DzjqHXradA-Be9Aot5xp9K_iG3J64Ptq9OaQw2nRvog3mWIhpa2yagxvQONdyELZXfVvOBt8VBHLPPChQqjQ35MOJdVi6Eb0r90h2eAJ92pnCzmzjb0OplErw1c27MyHFXwvm2YwhOxwGO2FcsuFUKFpMKF6kb_-T7uOSpvJWR5VUHFpWVG8eW_rr5c9XFsH1SdCN-38ECmbNiznnxax5Mae88AeRGbQx</recordid><startdate>20241218</startdate><enddate>20241218</enddate><creator>Chang, Rachel Si-Wen</creator><creator>Chiu, I-min</creator><creator>Tacon, Phillip</creator><creator>Abiragi, Michael</creator><creator>Cao, Louie</creator><creator>Hong, Gloria</creator><creator>Le, Jonathan</creator><creator>Zou, James</creator><creator>Daluwatte, Chathuri</creator><creator>Ricchiuto, Piero</creator><creator>Ouyang, David</creator><general>British Cardiovascular Society</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><scope>9YT</scope><scope>ACMMV</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-8969-2757</orcidid></search><sort><creationdate>20241218</creationdate><title>Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements</title><author>Chang, Rachel Si-Wen ; Chiu, I-min ; Tacon, Phillip ; Abiragi, Michael ; Cao, Louie ; Hong, Gloria ; Le, Jonathan ; Zou, James ; Daluwatte, Chathuri ; Ricchiuto, Piero ; Ouyang, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Accuracy</topic><topic>Aged</topic><topic>Amyloidosis</topic><topic>Amyloidosis - diagnosis</topic><topic>Amyloidosis - diagnostic imaging</topic><topic>Amyloidosis - physiopathology</topic><topic>Artificial intelligence</topic><topic>Cardiac arrhythmia</topic><topic>Cardiomyopathies - diagnosis</topic><topic>Cardiomyopathies - diagnostic imaging</topic><topic>Cardiomyopathies - physiopathology</topic><topic>Cardiomyopathy, Restrictive</topic><topic>Cardiovascular disease</topic><topic>Coronary vessels</topic><topic>Deep learning</topic><topic>Diabetes</topic><topic>Diagnostic Imaging</topic><topic>Echocardiography</topic><topic>Echocardiography - methods</topic><topic>Ejection fraction</topic><topic>Feature selection</topic><topic>Female</topic><topic>Heart failure</topic><topic>Heart Failure and Cardiomyopathies</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Machine Learning</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original Research</topic><topic>Patients</topic><topic>Performance evaluation</topic><topic>Predictive Value of Tests</topic><topic>Pulmonary arteries</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Statistical analysis</topic><topic>Ultrasonic imaging</topic><topic>Vein & artery diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Rachel Si-Wen</creatorcontrib><creatorcontrib>Chiu, I-min</creatorcontrib><creatorcontrib>Tacon, Phillip</creatorcontrib><creatorcontrib>Abiragi, Michael</creatorcontrib><creatorcontrib>Cao, Louie</creatorcontrib><creatorcontrib>Hong, Gloria</creatorcontrib><creatorcontrib>Le, Jonathan</creatorcontrib><creatorcontrib>Zou, James</creatorcontrib><creatorcontrib>Daluwatte, Chathuri</creatorcontrib><creatorcontrib>Ricchiuto, Piero</creatorcontrib><creatorcontrib>Ouyang, David</creatorcontrib><collection>BMJ Open Access Journals</collection><collection>BMJ Journals:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Open heart</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Rachel Si-Wen</au><au>Chiu, I-min</au><au>Tacon, Phillip</au><au>Abiragi, Michael</au><au>Cao, Louie</au><au>Hong, Gloria</au><au>Le, Jonathan</au><au>Zou, James</au><au>Daluwatte, Chathuri</au><au>Ricchiuto, Piero</au><au>Ouyang, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements</atitle><jtitle>Open heart</jtitle><stitle>Open Heart</stitle><addtitle>Open Heart</addtitle><date>2024-12-18</date><risdate>2024</risdate><volume>11</volume><issue>2</issue><spage>e002884</spage><pages>e002884-</pages><issn>2053-3624</issn><issn>2398-595X</issn><eissn>2053-3624</eissn><abstract>BackgroundCardiac amyloidosis (CA) is an underdiagnosed, progressive and lethal disease. Machine learning applied to common measurements derived from routine echocardiogram studies can inform suspicion of CA.ObjectivesOur objectives were to test a random forest (RF) model in detecting CA.MethodsWe used 3603 echocardiogram studies from 636 patients at Cedars-Sinai Medical Center to train an RF model to predict CA from echocardiographic parameters. 231 patients with CA were compared with 405 control patients with negative pyrophosphate scans or clinical diagnosis of hypertrophic cardiomyopathy. 19 common echocardiographic measurements from echocardiogram reports were used as input into the RF model. Data was split by patient into a training data set of 2882 studies from 486 patients and a test data set of 721 studies from 150 patients. The performance of the model was evaluated by area under the receiver operative curve (AUC), sensitivity, specificity and positive predictive value (PPV) on the test data set.ResultsThe RF model identified CA with an AUC of 0.84, sensitivity of 0.82, specificity of 0.73 and PPV of 0.76. Some echocardiographic measurements had high missingness, suggesting gaps in measurement in routine clinical practice. Features that were large contributors to the model included mitral A-wave velocity, global longitudinal strain (GLS), left ventricle posterior wall diameter end diastolic (LVPWd) and left atrial area.ConclusionMachine learning on echocardiographic parameters can detect patients with CA with accuracy. Our model identified several features that were major contributors towards identifying CA including GLS, mitral A peak velocity and LVPWd. Further study is needed to evaluate its external validity and application in clinical settings.</abstract><cop>England</cop><pub>British Cardiovascular Society</pub><pmid>39694574</pmid><doi>10.1136/openhrt-2024-002884</doi><orcidid>https://orcid.org/0000-0002-8969-2757</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2053-3624 |
ispartof | Open heart, 2024-12, Vol.11 (2), p.e002884 |
issn | 2053-3624 2398-595X 2053-3624 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_cc8304af7f82460db39ee3d2d07077c8 |
source | BMJ Open Access Journals; Publicly Available Content Database; PubMed Central |
subjects | Accuracy Aged Amyloidosis Amyloidosis - diagnosis Amyloidosis - diagnostic imaging Amyloidosis - physiopathology Artificial intelligence Cardiac arrhythmia Cardiomyopathies - diagnosis Cardiomyopathies - diagnostic imaging Cardiomyopathies - physiopathology Cardiomyopathy, Restrictive Cardiovascular disease Coronary vessels Deep learning Diabetes Diagnostic Imaging Echocardiography Echocardiography - methods Ejection fraction Feature selection Female Heart failure Heart Failure and Cardiomyopathies Humans Hypertension Machine Learning Male Middle Aged Original Research Patients Performance evaluation Predictive Value of Tests Pulmonary arteries Reproducibility of Results Retrospective Studies Statistical analysis Ultrasonic imaging Vein & artery diseases |
title | Detection of cardiac amyloidosis using machine learning on routine echocardiographic measurements |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T18%3A12%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detection%20of%20cardiac%20amyloidosis%20using%20machine%20learning%20on%20routine%20echocardiographic%20measurements&rft.jtitle=Open%20heart&rft.au=Chang,%20Rachel%20Si-Wen&rft.date=2024-12-18&rft.volume=11&rft.issue=2&rft.spage=e002884&rft.pages=e002884-&rft.issn=2053-3624&rft.eissn=2053-3624&rft_id=info:doi/10.1136/openhrt-2024-002884&rft_dat=%3Cproquest_doaj_%3E3147673082%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b2464-5b61e99c29fda90e790160f656267273e9bbcebacced68bc003d4f7ea339ed843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3147673082&rft_id=info:pmid/39694574&rfr_iscdi=true |